Therapy using stem cells derived from donor umbilical cords may help improve outcomes in infants with biliary atresia who…
Articles by Marisa Wexler, MS
New modeling data predict that bemnifosbuvir and ruzasvir, an experimental combination treatment being developed by Atea Pharmaceuticals for…
Treatment with melatonin, a naturally occurring hormone best known for regulating sleep, may help reduce liver injury caused by…
Long-term treatment with Rezdiffra (resmetirom) reduces liver scarring and other signs of advanced disease in adults with high-risk compensated cirrhosis…
HU6, an experimental oral therapy from Rivus Pharmaceuticals, safely and effectively reduced liver fat and led to fat-selective weight…
Enrollment is now complete for Vir Biotechnology’s global ECLIPSE 1 trial, which is testing the combination treatment of tobevibart and…
Exposure to a human-made chemical called perfluoroheptanoic acid (PFHpA) may increase the risk and severity of fatty liver disease…
The European Medicines Agency (EMA) has granted orphan drug designation to Suzhou Ribo Life Science’s experimental therapy RBD1016 for…
Oct. 29 is Global PSC Awareness Day, and advocates around the world are joining forces to shine a light on…
A long-term ketogenic diet, which favors fats over carbs, may promote weight loss, but it can also cause fatty…